Wilkinson Adam C, Kawata Viviane K S, Schütte Judith, Gao Xuefei, Antoniou Stella, Baumann Claudia, Woodhouse Steven, Hannah Rebecca, Tanaka Yosuke, Swiers Gemma, Moignard Victoria, Fisher Jasmin, Hidetoshi Shimauchi, Tijssen Marloes R, de Bruijn Marella F T R, Liu Pentao, Göttgens Berthold
Cambridge Institute for Medical Research and Wellcome Trust-MRC Cambridge Stem Cell Institute, University of Cambridge, Hills Road, Cambridge CB2 0XY, UK.
Cambridge Institute for Medical Research and Wellcome Trust-MRC Cambridge Stem Cell Institute, University of Cambridge, Hills Road, Cambridge CB2 0XY, UK Division of Periodontology and Endodontology, Tohoku University Graduate School of Dentistry, Sendai 980-8575, Japan.
Development. 2014 Oct;141(20):4018-30. doi: 10.1242/dev.115709. Epub 2014 Sep 24.
Transcription factors (TFs) act within wider regulatory networks to control cell identity and fate. Numerous TFs, including Scl (Tal1) and PU.1 (Spi1), are known regulators of developmental and adult haematopoiesis, but how they act within wider TF networks is still poorly understood. Transcription activator-like effectors (TALEs) are a novel class of genetic tool based on the modular DNA-binding domains of Xanthomonas TAL proteins, which enable DNA sequence-specific targeting and the manipulation of endogenous gene expression. Here, we report TALEs engineered to target the PU.1-14kb and Scl+40kb transcriptional enhancers as efficient new tools to perturb the expression of these key haematopoietic TFs. We confirmed the efficiency of these TALEs at the single-cell level using high-throughput RT-qPCR, which also allowed us to assess the consequences of both PU.1 activation and repression on wider TF networks during developmental haematopoiesis. Combined with comprehensive cellular assays, these experiments uncovered novel roles for PU.1 during early haematopoietic specification. Finally, transgenic mouse studies confirmed that the PU.1-14kb element is active at sites of definitive haematopoiesis in vivo and PU.1 is detectable in haemogenic endothelium and early committing blood cells. We therefore establish TALEs as powerful new tools to study the functionality of transcriptional networks that control developmental processes such as early haematopoiesis.
转录因子(TFs)在更广泛的调控网络中发挥作用,以控制细胞身份和命运。许多转录因子,包括Scl(Tal1)和PU.1(Spi1),都是发育和成人造血过程中已知的调节因子,但它们在更广泛的转录因子网络中如何发挥作用仍知之甚少。转录激活样效应因子(TALEs)是一类新型的遗传工具,基于黄单胞菌TAL蛋白的模块化DNA结合结构域,可实现DNA序列特异性靶向和对内源基因表达的操纵。在此,我们报告了经过工程改造以靶向PU.1 - 14kb和Scl + 40kb转录增强子的TALEs,它们是干扰这些关键造血转录因子表达的有效新工具。我们使用高通量RT-qPCR在单细胞水平上证实了这些TALEs的效率,这也使我们能够评估在发育性造血过程中PU.1激活和抑制对更广泛转录因子网络的影响。结合全面的细胞分析,这些实验揭示了PU.1在早期造血特化过程中的新作用。最后,转基因小鼠研究证实,PU.1 - 14kb元件在体内确定性造血部位具有活性,并且在造血内皮细胞和早期定向血细胞中可检测到PU.1。因此,我们将TALEs确立为研究控制早期造血等发育过程的转录网络功能的强大新工具。